NCATS encourages early career investigators from a wide range of disciplines and perspectives to apply. The opportunity may also be of interest to junior investigators focusing their research on some component of the opioid epidemic. Through the Administrative Supplement to Enhance Network Capacity, Collaborative Opportunities for the CTSA Program, the University at Buffalo Clinical and Translational Science Institute in partnership with the Vanderbilt Institute for Clinical and Translational Research will test and measure innovative methods of fostering team science while helping early-career researchers from diverse disciplines generate novel, successful grant proposals. The five-day residential Innovation Labs focus on grand challenges in clinical and translational research. The labs will bring ~25 participants from across the CTSA Program network together with facilitators and content experts who guide participants through the early stages of proposal development.

by Sherry Edwards, CCRC
Have you ever considered participating in medical research but thought “I am healthy; clinical research is for people who are ill” – not true! Healthy people contribute to medical advances by providing information about the “normal” state of health. In clinical research, healthy individuals participate as controls or “the norm” to compare with the condition under investigation. Research ...

The foundation supports independent, peer-reviewed musculoskeletal research and education seeking clinically relevant advances that orthopaedic surgeons can apply in daily practice to improve outcomes and help patients enjoy more of life. To that end, OREF, in partnership with the Musculoskeletal Transplant Foundation, is accepting applications from new investigators for research on biologic skeletal reconstruction, including implants and stem cells.

POCTRN's purpose is to drive the development and application of appropriate point-of-care technologies through collaborative efforts that merge scientific and technological capabilities with clinical need. The POCTRN Research Centers will create a national research network that works to build expertise in the development of integrated systems that address unmet clinical needs in point-of-care testing and treatment through the creation of multidisciplinary partnerships.

The UDN is a research study with three overarching goals improve the level of diagnosis and care for patients with undiagnosed diseases, to facilitate research into the etiology of undiagnosed diseases, and to promote an integrated and collaborative community of laboratory and clinical investigators prepared to investigate these difficult to diagnose diseases. A webinar for potential applicants will be held on September 14, at 3:00 p.m.

The program is designed to support physician-investigators at the level of advanced fellow or junior faculty member who can contribute to the development of new lymphoma therapies and diagnostic tools. The goal of the program is to prepare physician-investigators to design and administer clinical research studies in lymphoma and assume primary responsibilities for clinical research, protocol writing, Institutional Review Board (IRB) submission, and publication.

Emory School of Medicine is pleased to announce the opening of the new Emory Stem Cell Core (ESCC) as the newest member of the Emory Integrated Core Facilities (EICF). This core¿s focus and technical expertise will be to derive and characterize human induced pluripotent stem cells (iPSCs) from terminally differentiated somatic cells using non-integrating methods. Additionally, the core will provide training and educational resources to support investigators with interest in human stem cells. IPSCs generated from patients with a genetic defect allows for a unique opportunity to study the mechanisms of disease in an in vitro model. Other applications for these cells include developing a reporter line, drug screening and discovery, and potentially regenerative therapies. The core plans to interface with other members of the Emory Integrated Core Facilities as a pipeline to analyze patient cells that will inform drug discovery and personalized medicine. The ESCC will be led by Megan Merritt, MS as the Core Director and is located in the Whitehead Building, room 429. Professor and Chair of Cell Biology, Gary Bassell, PhD will serve as the Scientific Director for the ESCC.

Join Georgia Bio's Emerging Leaders Network for an Augusta-area Small Dinner event featuring William Hamilton, MBA, MHA, REACH Health (telemedicine company) Founder and Assistant Dean for Administration for the College of Nursing at Augusta University. He also serves as an Assistant Professor of Physiological and Technological Nursing and conducts research focusing on innovation in the practice of nursing.

Pediatric Infectious Diseases at Emory Children's Center is working on a research study to test the safety and tolerability of a microneedle patch. They need healthy infants and children between the age of six weeks and 24 months to volunteer for the study. Infants and children who participate in this study will have three clinic appointments at Emory Children's Center. Compensation will be provided.

E2E trials are designed to address the effectiveness and safety gaps that often occur in standard randomized controlled trials, and offer an opportunity for improved understanding of how a treatment will work in more usual real-world clinical settings. E2E trial design is an approach whereby an effectiveness trial is prospectively designed to commence seamlessly upon completion of the efficacy trial. This involves the development of suitable efficacy and effectiveness endpoints, advice on the statistical analysis plan, and a detailed plan for systematic transition from the successful efficacy trial into an effectiveness trial, including the role of the DSMB in this context.

NCATS Office of Rare Diseases Research (ORDR) will be hosting a webinar featuring Holm Graessner, PhD, MBA, Coordinator, ERN-RND, and Enrique Terol of the European Commission. The purpose of this presentation is to provide information on the European Reference Networks (ERNs) for Rare Diseases, and to explore potential areas for research collaboration with the European Union.

ASOM's goal is to improve mentoring culture and build communities on campus as well as raise awareness of resources that enable faculty to maximize and leverage mentoring relationships with the graduate students and postdoctoral fellows.

The goal of this workshop is to address challenges and opportunities for impactful clinical trials in medical rehabilitation, such as trial design, issues in recruitment and retention, mobile technology integration, multi-modal interventions, control groups, response heterogeneity, rigor and reproducibility, and data and safety monitoring. Following an introductory lecture, workshop participants will divide into breakout sessions based on their experience level as investigators. Registration is free but space is limited. Travel award opportunities available.

This workshop, hosted by NCATS, will focus on defining collaborative opportunities, addressing challenges and applying best practices in translational iPSC research. Topics of interest are quality control standards for pluripotency, safety, experimental reproducibility, cost-efficient scalability and manufacturing, improved and efficient differentiation protocols, advances in -omics and functional characterization of cell type identities, and other relevant questions.

Presented by David Nash, MD, MBA, Dean, Jefferson College of Public Health, Thomas Jefferson University. Hosted by Emory-Georgia Tech Healthcare Innovation Program and the Georgia CTSA from noon to 2:00 p.m. in Emory School of Medicine auditorium 120. ...

Registration is now open. CFAR at Emory, Emory Center for Health in Aging, and the Emory School of Nursing is hosting the conference which includes a competitive, pre-conference Mentoring Workshop for early-career investigators and poster session. Abstracts are due on August 25.

For more information on ACTSI, please visit
www.actsi.org. Do you have news, seminars, or events of interest to clinical and translational researchers? Send them to
actsi@emory.edu by noon on Thursday. To suggest subscribers or unsubscribe to the listserv please email
actsi@emory.edu.

Please include the following citation in any publications resulting from direct or indirect ACTSI support, "Supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR000454. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health." KL2 Scholars should also list KL2 TR000455 and TL1 Trainees should also list TL1 TR000456.